We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App





World's First Confirmed Case of COVID-19 Re-Infection Raises Questions Over Coronavirus Immunity

By HospiMedica International staff writers
Posted on 27 Aug 2020
Print article
Illustration
Illustration
Researchers have reported the world’s first confirmed case of COVID-19 re-infection, raising questions about the durability of immune protection from the SARS-CoV-2 virus.

Researchers have confirmed that a 33-year-old man was first infected by SARS-CoV-2 in late March and then again contracted the virus after four and a half months while traveling in Europe, according to a report by STAT. There have been reports earlier of cases of COVID-19 re-infection, although they were based on anecdotal evidence and had been attributed mainly to flaws in testing. However, in this latest case of COVID-19 re-infection, researchers from the University of Hong Kong (Hong Kong) sequenced the virus from the patient’s two infections and found that they did not match, indicating that the second infection was not linked to the first. The researchers found a difference of 24 nucleotides, the “letters” that make up the virus’ RNA, between the two infections.

The finding of the world’s first confirmed case of COVID-19 re-infection comes amidst concerns over how long one can remain protected from the SARS-CoV-2 virus after being infected and recovering. Various studies have found that the majority of recovered COVID-19 patients generate a robust immune response involving both antibodies (molecules that can block the virus from infecting cells again) and T cells (which can help clear the virus), according to the STAT report. This indicates protection from repeat COVID-19 infection could last for some time. However, experts believe that immunity to SARS-CoV-2 cannot last forever as people generally once again become susceptible to the coronaviruses that cause common cold after a year or even less, and remain protected against SARS-1 and MERS for just a few years.

Nevertheless, experts believe that the Hong Kong case is rare and unprecedented among the tens of millions of cases globally and immune protection to COVID-19 may generally last more than a few months. More definitive conclusions could be reached only after the conclusion of studies currently tracking patients who have recovered from COVID-19. Additionally, experts have pointed out that that the Hong Kong man’s second case was milder than his first, indicating that his immune system was providing some protection against the SARS-CoV-2 virus, even if it failed to prevent re-infection entirely, according to STAT.

“There’s been more than 24 million cases reported to date,” Maria Van Kerkhove, a coronavirus expert at the World Health Organization, said at a briefing, when asked about the Hong Kong report. “And we need to look at something like this at a population level. What we are learning about infection is that people do develop an immune response, and what is not completely clear yet is how strong that immune response is and for how long that immune response lasts.”

Related Links:
University of Hong Kong

New
Gold Member
X-Ray QA Meter
T3 AD Pro
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Hospital Data Analytics Software
OR Companion
New
Monitor Cart
Tryten S5

Print article

Channels

Surgical Techniques

view channel
Image: The new treatment combination for subdural hematoma reduces the risk of recurrence (Photo courtesy of Neurosurgery 85(6):801-807, December 2019)

Novel Combination of Surgery and Embolization for Subdural Hematoma Reduces Risk of Recurrence

Subdural hematomas, which occur when bleeding happens between the brain and its protective membrane due to trauma, are common in older adults. By 2030, chronic subdural hematomas are expected to become... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.